Trials / Sponsors / Oryzon Genomics S.A.
Oryzon Genomics S.A.
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mu Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory | Phase 1 | 2022-11-14 |
| Completed | Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population Borderline Personality Disorder | Phase 2 | 2021-03-26 |
| Completed | Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease Mild to Moderate Alzheimer's Disease | Phase 2 | 2019-05-16 |